

Reyo Medtech is advancing minimally invasive treatments designed to help clinicians better target the source of chronic lower back pain.
What We Do
We have redefined and optimized
Basivertebral Nerve Ablation (BVNA)
into a distinctive yet familiar procedure.
Chronic low back pain is the leading cause of disability worldwide and the most expensive occupational disorder in the United States, with 1 in 5 patients having pain originating from the vertebra, where BVNA is the only effective treatment.
What We Do
REYO® is advancing minimally invasive treatments designed to help clinicians better target the source of chronic lower back pain.
Chronic low back pain is the leading cause of disability worldwide and the most expensive occupational disorder in the United States, with more than 30% of the population affected by low back pain at any given time.
Its effects reach far beyond discomfort, impacting mobility, confidence, quality of life, workplaces, and healthcare systems.
Chronic low back pain is the leading cause of disability worldwide and the most expensive occupational disorder in the United States, with more than 30% of the population affected by low back pain at any given time.
Its effects reach far beyond discomfort, impacting mobility, confidence, quality of life, workplaces, and healthcare systems.
Relief, Reimagined
Beam Medical is advancing minimally invasive treatments designed to help clinicians better target the source of chronic lower back pain.
Same effective treatment.
Same reimbursement structure.
Drastically easier and faster.
Investigational Device Notice: The Reyo Medtech Intraosseous Nerve Ablation System is currently under development and has not been cleared or approved by the U.S. Food and Drug Administration (FDA). The device is not available for commercial sale in the United States. Any descriptions of the device, its features, performance, or potential clinical benefits are for informational purposes only and do not constitute claims of safety or effectiveness. Future regulatory clearance or approval is subject to FDA review and cannot be guaranteed.

Even retain the option for effortless readjustment at any point during the intervention.
Access
Patent-pending access system allows for novel freedom in a familliar clinical approach.
Target
Aim and visualize the trajectory in an intuitive manner. Adjust as needed for optimal positioning.
Ablate
Simultaneous ablations for improved efficiency. Leveraging existing generators for simplicity.
The Difference
What Makes Our Devices Different?
01
Access
Patent-pending access system allows for novel freedom in a familliar clinical approach.
02
Target
Aim and visualize the trajectory in an intuitive manner. Adjust as needed for optimal positioning.
03
Ablate
Simultaneous ablations for improved efficiency. Leveraging existing generators for simplicity.
04
Readjustment
Even retain the option for effortless readjustment at any point during the intervention.
The Difference
What Makes Our Devices Different?
01
Access
Patent-pending access system allows for novel freedom in a familliar clinical approach.
02
Target
Aim and visualize the trajectory in an intuitive manner. Adjust as needed for optimal positioning.
03
Ablate
Simultaneous ablations for improved efficiency. Leveraging existing generators for simplicity.
04
Readjustment
Even retain the option for effortless readjustment at any point during the intervention.
The Difference
What Makes Our Devices Different?


© Reyo Medtech 2026








